文献速递中医内科中药与中成药合理使用

中药联合西药治疗2型糖尿病合并高尿酸血症的系统评价与Meta分析

Chinese herbal medicine combined with western medicine for the treatment of type 2 diabetes mellitus with hyperuricemia: A systematic review and meta-analysis.
PubMed 文献 · Front Pharmacol · 2023-01-24

该系统评价纳入18项RCT共1311例患者,评估中药联合西药治疗T2DM合并HUA的疗效与安全性。结果显示联合治疗在FBG、2hPG、HbA1c、UA、TG、TC及总有效率方面均优于单用西药,但证据质量均为低。

要点

  • 中药联合西药可显著改善T2DM合并HUA患者的血糖、尿酸和血脂指标。
  • 联合治疗总有效率优于单用西药,RR=1.29(95%CI 1.13–1.48)。
  • 证据质量均为低,结论需高质量RCT进一步验证。

核心结论

  • 与单用西药相比,中药联合西药治疗T2DM合并HUA在改善糖代谢、尿酸和血脂方面更有效。
  • 因证据质量低且异质性高,需高质量RCT进一步评估。

研究设计与样本

  • 系统评价与Meta分析,检索8个数据库至2022年11月,纳入18项RCT共1311例患者。
  • 方案注册于PROSPERO(CRD42022351519)。

主要发现

  • FBG:WMD=-0.60,95%CI [-0.81, -0.40],p<0.00001。
  • 2hPG:WMD=-1.12,95%CI [-1.64, -0.60],p<0.0001。
  • HbA1c:WMD=-0.80,95%CI [-1.04, -0.56],p<0.00001。
  • UA:WMD=-53.47,95%CI [-67.45, -39.48],p<0.00001。
  • TG:WMD=-0.56,95%CI [-0.74, -0.38];TC:WMD=-0.49,95%CI [-0.65, -0.33],均p<0.00001。

关键数值与推荐

  • 总有效率:RR=1.29,95%CI [1.13, 1.48],p=0.0002。
  • 所有结局的证据质量均为低。

临床怎么用

  • 在临床中可考虑中药联合西药用于T2DM合并HUA患者,以改善血糖、尿酸和血脂。
  • 需结合低证据质量背景,个体化评估后使用。

局限性

  • 纳入研究的证据质量低。
  • 存在高异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Chinese herbal medicine (CHM) has the advantage of being safe and effective and has been widely used in clinical practice for the treatment of type 2 diabetes mellitus (T2DM) with hyperuricemia (HUA), but its overall efficacy and safety remain unclear. This study aimed to evaluate the efficacy and safety of CHM for the treatment of T2DM with HUA based on randomized controlled trials (RCTs) to provide clinical evidence. Methods: The protocol evaluated in this study is registered with PROSPERO (CRD42022351519). As of November 2022, eight databases were searched, and RCTs of CHM for the treatment of T2DM with HUA were included. Outcome indicators observed included fasting blood glucose (FBG), 2-h postprandial glucose (2hPG), glycated hemoglobin (HbA1c), uric acid (UA), triglycerides (TG), total cholesterol (TC), overall effectiveness, and adverse events. Utilizing Review Manager 5.4, Stata V14.0, and GRADEpro, the included studies were evaluated, and the quality of the evidence was determined. Results: 18 RCTs covering 1,311 patients were included in this study. The results of the study demonstrated that the combination of CHM and western medicine (WM) was more effective in treating patients with T2DM with HUA than WM alone, with significant improvements in FBG (weighted mean differences (WMD) = -0.60.95% confidence interval (CI) [-0.81, -0.40], p < 0.00001), 2hPG (WMD = -1.12.95% CI [-1.64, -0.60], p < 0.0001), HbA1c (WMD = -0.80.95% CI [-1.04, -0.56], p < 0.00001), UA (WMD = -53.47.95% CI [-67.45, -39.48], p < 0.00001), TG (WMD = -0.56.95% CI [-0.74, -0.38], p < 0.00001), TC (WMD = -0.49.95% CI [-0.65, -0.33], p < 0.00001), and overall effective rate (risk ratio (RR) = 1.29.95%CI [1.13, 1.48], p = 0.0002). The quality of evidence for all outcomes was low. Conclusion: Compared with WM alone, the combination of CHM and WM was more effective in treating patients with T2DM with HUA, with significant improvements in glucose metabolism, uric acid, and lipids. However, further evaluation by high-quality RCT results is needed due to the low quality and high heterogeneity of the evidence. Systematic Review Registration: [https://systematicreview.gov/], identifier [CRD42022351519].

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Liu H, Peng S, Yuan H, et al. Chinese herbal medicine combined with western medicine for the treatment of type 2 diabetes mellitus with hyperuricemia: A systematic review and meta-analysis. Front Pharmacol. 2023. PMID: 36762115. doi:10.3389/fphar.2023.1102513

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。